Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases (Q26863752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

1 reference

title

Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Bojan Stanimirov

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Karmen Stankov

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

1 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary & Pancreatic Diseases International

29 February 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

14

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

18-33

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

Pleiotropic roles of bile acids in metabolism

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

FXR signaling in the enterohepatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Perspective: TGR5 (Gpbar-1) in liver physiology and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Structure and origin of bile acids: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Fifty years of advances in bile acid synthesis and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile-acid-induced cell injury and protection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acid regulation of gene expression: roles of nuclear hormone receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

FXR and PXR: potential therapeutic targets in cholestasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Hepatobiliary membrane transporters in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile salts and their importance for drug absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Host-gut microbiota metabolic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile salts of vertebrates: structural variation and possible evolutionary significance

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Role of the intestinal bile acid transporters in bile acid and drug disposition

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Transport and biological activities of bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids: regulation of synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

A role of the bile salt receptor FXR in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

FXR, a multipurpose nuclear receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Farnesoid X receptor: from structure to potential clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids: from digestion to cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Role of bile acids and bile acid receptors in metabolic regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

FXR: a metabolic regulator and cell protector

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Identification of a chemical tool for the orphan nuclear receptor FXR.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Identification of membrane-type receptor for bile acids (M-BAR)

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Endocrine and paracrine role of bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

A G protein-coupled receptor responsive to bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The bile acid TGR5 membrane receptor: from basic research to clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Physiology of FGF15/19

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Circulating fibroblast growth factors as metabolic regulators--a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptors in liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptors in bile acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids as regulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acid receptors in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptors as new perspective for the management of liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Targeting bile-acid signalling for metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Targeting farnesoid X receptor for liver and metabolic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

TGR5-mediated bile acid sensing controls glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptors as drug targets in cholestatic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptors as therapeutic targets in cholestatic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Regulation of bile acid synthesis by fat-soluble vitamins A and D.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

ABCB4 gene mutation-associated cholelithiasis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Effects of obesity and caloric intake on biliary lipid metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Cholelithiasis and the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Deciphering the nuclear bile acid receptor FXR paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear bile acid receptor FXR in the hepatic regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Molecular mechanisms of altered bile acid homeostasis in organic solute transporter-alpha knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Inhibition of ileal bile acid transport lowers plasma cholesterol levels by inactivating hepatic farnesoid X receptor and stimulating cholesterol 7 alpha-hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Intestinal bile acid physiology and pathophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Expression and function of the bile acid receptor TGR5 in Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile salts regulate intestinal epithelial cell migration by nuclear factor-kappa B-induced expression of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids as endogenous etiologic agents in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids in the colon, from healthy to cytotoxic molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Field defects in progression to gastrointestinal tract cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Probiotics--interactions with bile acids and impact on cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Unconjugated secondary bile acids in the serum of patients with colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile flow and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Diet, fecal water, and colon cancer--development of a biomarker

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Deoxycholic Acid Induces Intracellular Signaling through Membrane Perturbations

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

A "field change" of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Molecular determinants of gastrointestinal and liver cancers: role of bile acid activated nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Carcinogenicity of deoxycholate, a secondary bile acid

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids: regulation of apoptosis by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Bile acids and colon cancer: Solving the puzzle with nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Targeting the p53 pathway of apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Nuclear bile acid receptor FXR protects against intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

Human cecal bile acids: concentration and spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2814%2960307-6

7 January 2021

10.1016/S1499-3872(14)60307-6

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1352993

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1352993

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

1352993

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25655287%20AND%20SRC:MED&resulttype=core&format=json